Back to Studies
P1088 / H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Perinatally Infected Children and Youth
Study Status
Concluded
DAIDS Number
10840
IND Number
BB 14147
Primary Protocol Team Members
Summary
P1088 was a multi-center, Phase II, open label study of an inactivated Influenza A (H1N1) 2009 monovalent vaccine. The study was designed to determine the safety and immunogenicity after each of two doses of Influenza A (H1N1) 2009 Monovalent Vaccine in HIV-1 perinatally infected children and youth.
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...